Introduction
============

Autism spectrum disorders (ASDs), a group of neurodevelopmental disorders among children, are manifesting a dramatically increased prevalence in most societies \[[@b1-kjp-2019-00815]\]. Deficits in verbal and non-verbal communication, restricted and repetitive patterns of behavior, and impaired social preferences are observed among children with ASD \[[@b2-kjp-2019-00815]\]. While the etiology of ASD is unknown, evidence that genetic factors, environmental characteristics, and pregnancy complications such as preeclampsia and antenatal hemorrhage are involved in its pathogenesis \[[@b3-kjp-2019-00815]-[@b6-kjp-2019-00815]\].

Unconjugated hyperbilirubinemia (jaundice) is common in the first days after birth. Heme catabolism produces the bilirubin, a low level of which is beneficial and acts as an antioxidant agent; however, in higher concentrations, can be neurotoxic to neuronal cells in neonates \[[@b7-kjp-2019-00815]\]. The literature shows that the prevalence of jaundice is 50% and 80% in term and preterm neonates, respectively \[[@b8-kjp-2019-00815]\].

The risk of ASD in relation with neonatal jaundice has been investigated previously. Some studies showed a significant association \[[@b9-kjp-2019-00815]-[@b11-kjp-2019-00815]\], while some others demonstrated no association \[[@b12-kjp-2019-00815]-[@b14-kjp-2019-00815]\]. To date, only one meta-analysis examined the association between neonatal jaundice and the risk of ASD \[[@b15-kjp-2019-00815]\]. The authors reorted a significant correlation between neonatal jaundice and the risk of ASD among children (odds ratio \[OR\], 1.43; 95% confidence interval \[CI\], 1.22--1.67). However, that meta-analysis was limited to the PubMed and MEDLINE databases and included only studies published through 2009. Therefore, the current meta-analysis pooled all case-control and cohort studies within 3 databases to determine the risk of ASD in children in relation with neonatal jaundice.

Methods
=======

1. Data sources
---------------

The present meta-analysis assessed the association between neonatal jaundice and the risk of ASD among children. We systematically searched for relevant studies using the published PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement checklist. We identified all studies published through April 2018 in the Web of Science, PubMed, and Scopus databases and manually checked the reference lists of the published manuscripts.

The protocol of this study with the code of 9703081248 was approved by Hamadan University of Medical Sciences.

2. Search strategy
------------------

The index terms used in the present meta-analysis included: (autism or ASDs) and (jaundice or hyperbilirubinemia or icterus) and (infants or neonates or neonatal). We searched studies regardless of language of publication.

3. Inclusion and exclusion criteria
-----------------------------------

In this systematic search, studies that evaluated the association between neonatal jaundice measured by total serum bilirubin (TSB) and the risk of ASD among children were included. Case reports, case series studies, reviews, letters to the editor, and multiple publications on the same material from the same author were excluded.

4. Data extraction
------------------

The titles were screened first, followed by the abstracts and full texts of the included studies by 2 authors (SK and EJ). The predesigned extraction form included publication year, first author, country, study design, ASD diagnostic criteria, number of participants, OR, rate ratio (RR) and the associated 95% CI, adjustment for confounders, child age (range), and study quality. The confounding variables related to the correlation between neonatal jaundice and the risk of ASD among children in the included studies were sex, maternal age, child's birth year, birth season, prematurity, multiple gestation, birth order, and level of urbanization.

5. Quality assessment
---------------------

We used the improved Newcastle-Ottawa Scale (NOS) to assess the quality of the included studies \[[@b16-kjp-2019-00815]\]: comparability using 2 items, election using 4 items, and exposure or outcomes using 3 items with scores of 0--9. The quality assessment of included studies was performed independently by 2 authors (SK and EJ). Finally, According to NOS scale, the studies were categorized as low quality (\<7 points) and high quality (≥7 points).

6. Sensitivity analysis
-----------------------

We used a sequential algorithm to obtain the minimum desired I2 threshold (50%) \[[@b17-kjp-2019-00815]\]. Hence, we conducted 21 new meta-analyses in which one study for each was excluded from the estimations. The study was accountable for the greatest reduction in I2, and a new set of 1--21 studies was made. If by excluding 2 or more studies created the same decrease in the I2, the study with the greatest decrease in Q was excluded. The procedure was continued until the I2 diminished to the below of desired preset threshold. Finally, we revealed that a minimum I2 in one omitted study could result in the I2 falling below the desired threshold.

7. Statistical analysis
-----------------------

We calculated pooled OR, RR, and their 95% CI from eligible studies used as random effect estimates of association among studies. The subgroup analyses were performed according to crude and adjusted reporting of studies and preterm labor to identify potential sources of heterogeneity. To assess the degree of intergroup heterogeneity, the *I^2^* statistic was used. According to the *I^2^* statistic, low and high heterogeneity were considered at values of 25% and 75%, respectively.

The Begg and Egger's regression model was used to examine publication bias \[[@b18-kjp-2019-00815]\]. The statistical analyses were performed using Stata 13 (Stata Corp., College Station, TX, USA), and values of *P*\<0.05 were considered significant.

Results
=======

1. Description of studies
-------------------------

A total of 1,008 studies were included in the initial search by searching the mentioned major international databases for studies published until April 2018 and manually reviewing the reference lists. A total of 287 duplicates were identified and eliminated; the title and abstract review identified and eliminated another 681 irrelevant studies. Accordingly, 40 studies were subjected to further screening. Of them, 19 studies did not meet our eligibility criteria or were not original articles. Ultimately, 21 articles were included in the meta-analysis. The selection process of the included studies is presented in [Fig. 1](#f1-kjp-2019-00815){ref-type="fig"}. The meta-analysis included 5 cohort studies \[[@b19-kjp-2019-00815]-[@b23-kjp-2019-00815]\] and 16 case-control studies \[[@b9-kjp-2019-00815]-[@b14-kjp-2019-00815],[@b24-kjp-2019-00815]-[@b33-kjp-2019-00815]\] with a total of 826,330 participants. All included studies were published in English.

### 1) Main analysis

The correlation between jaundice in neonates and the risk of ASD among children is shown in a forest plot in [Fig. 2](#f2-kjp-2019-00815){ref-type="fig"}. The pooled estimates of OR and RR showed a significant association between neonatal jaundice and the risk of ASD among children (OR, 1.35; 95% CI, 1.02--1.68; and RR, 1.39; 95% CI, 1.05--1.74), respectively. There was moderate heterogeneity among the studies reporting the risk of ASD among children based on OR (*I^2^*=52.5%, P=0.006). However, there was no heterogeneity in the studies reporting the risk of ASD among children based on RR (*I^2^*=0.0%, P=0.457).

[Fig. 3](#f3-kjp-2019-00815){ref-type="fig"} shows asymmetry based on funnel plot shape. This asymmetry indicated evidence of no publication bias. The *P* values for Begg and Egger\'s regression were 0.090 and 0.056, respectively.

### 2) Subgroup analysis

The subgroup analyses were conducted based on the adjusted form of studies and preterm labor. The OR of the crude and adjusted studies were 1.75 (95% CI, 0.96--2.54) and 1.19 (95% CI, 1.07--1.30), respectively. A significant association was found in the adjusted studies, and no heterogeneity was identified among them ([Table 1](#t1-kjp-2019-00815){ref-type="table"}). There was no significant association between neonatal jaundice and ASD in preterm neonates (OR, 0.89; 95% CI, 0.65--1.13). Most of the enrolled studies had determined both preterm (\<37 weeks gestational age) and term neonates with jaundice, but only 4 studies \[[@b11-kjp-2019-00815],[@b19-kjp-2019-00815],[@b24-kjp-2019-00815],[@b26-kjp-2019-00815]\] separately assessed the association between neonatal jaundice and ASD in preterm and term neonates ([Table 2](#t2-kjp-2019-00815){ref-type="table"}).

### 3) Study quality

According to the NOS, only 2 of the included studies were categorized as low quality and others had high quality ([Table 2](#t2-kjp-2019-00815){ref-type="table"}).

2. Sensitivity analysis
-----------------------

We observed evidence for considerable intergroup heterogeneity. Thus, the sensitivity analysis was performed according to the sequential algorithm to gain interstudy homogeneity. We achieved the least desired *I^2^* threshold (50%) by ignoring 2 studies \[[@b12-kjp-2019-00815],[@b25-kjp-2019-00815]\] from the meta-analysis and the risk of ASD (OR, 1.31; 95% CI, 1.09--1.53; *I^2^*=10.9%).

Discussion
==========

In the present meta-analysis, the existing evidence derived from epidemiological studies related to assessing the association between the risk of ASD and neonatal jaundice was summarized. In this meta-analysis, we included all case-control and cohort studies to assess the correlation between neonatal jaundice and the risk of ASD among children in 21 individual studies. Our results indicated a significant association between neonatal jaundice and the risk of ASD among children. The pooled estimate of the included studies reported that the OR and RR of ASD among children with neonatal jaundice were 1.35 and 1.39, respectively. There was no heterogeneity among the studies that estimated the risk of ASD among children based on RR, while there was moderate heterogeneity among the studies that estimated the risk of ASD based on OR.

Only one meta-analysis was conducted on the risk of ASD in relation to neonatal jaundice. In 2011, Amin et al. \[[@b15-kjp-2019-00815]\] showed that neonatal jaundice was a risk factor for ASD among children (OR, 1.43; 95% CI, 1.22--1.67). This meta-analysis was restricted to 13 studies published until 2009 retrieved from the PubMed and MEDLINE databases, whereas the present study included searches of the PubMed, Scopus, Web of Science databases up to April 2018 and included 21 studies.

Maimburg et al. \[[@b26-kjp-2019-00815]\] and Sugie et al. \[[@b29-kjp-2019-00815]\] reported a dose-response association between neonatal jaundice and the risk of ASD among children. Other studies reported that the TSB concentration consists of free or bound unconjugated and conjugated bilirubin. The free unconjugated bilirubin can be bound to protein, while freely unconjugated or unbound bilirubin is neurotoxic and can cross the intact blood brain barrier \[[@b34-kjp-2019-00815]\].

In 2014, Bhutani et al. \[[@b7-kjp-2019-00815]\] showed that bilirubin-induced neurologic dysfunction may manifest as muscle tone abnormalities, neuromotor abnormalities, neurobehavior manifestations, hyperexcitable reflexes in neonates, abnormalities in speech and language, and dysfunctions in central processing.

In the present meta-analysis, the correlation between neonatal jaundice and ASD in preterm neonates was not significant. In preterm neonates, the binding affinity may change because of several endogenous and exogenous competitors of bilirubin for albumin binding, while the protein concentration may be lower. Therefore, despite the low concentration of TSB, the concentration of free unconjugated bilirubin can be considerably higher. Thus, it may be necessary to measure free unconjugated bilirubin in preterm neonates rather than relying on TSB values alone. In contrast, for term neonates, the correlation between TSB and free unconjugated bilirubin concentrations is reportedly a sensitive marker for bilirubin-induced neurotoxicity. Therefore, jaundice in term neonates may be a risk factor for ASD \[[@b35-kjp-2019-00815]\].

The present study has some limitations: (1) in some studies, no adjustment was made for confounding factors; (2) data that were presented by included studies were insufficient for a subgroup analysis; (3) different diagnostic criteria for ASD were used and some studies did not use standardized diagnostic instruments; and (4) not all of the included studies mentioned a correlation between blood bilirubin concentration and ASD. Also, jaundice levels were not unified.

The above limitations might enhance the probability of selection bias. However, this meta-analysis evaluated the association between neonatal jaundice and ASD among 826,330 participants.

Neonatal jaundice may be associated with ASD in children. Despite existing controversy, our findings indicated that neonatal jaundice may increase the risk of ASD among children.

No potential conflict of interest relevant to this article was reported.
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###### 

Results of subgroup analysis of neonatal jaundice and autism spectrum disorders

  Subgroup                              Studies                       
  ------------------------------------- --------- ------------------- -------
  Adjusted form (studies based on OR)                                 
   Crude analysis                       11        1.75 (0.96--2.54)   64.9%
   Adjusted analysis                    6         1.19 (1.07--1.30)   0%
  Gestational age                                                     
   Preterm delivery                     4         0.89 (0.65--1.13)   0%
   Term delivery                        4         1.20 (1.08--1.32)   0%

OR, odds ratio; CI, confidence interval.

###### 

Summary results of the included studies

  Study                                               Country   Design         Sample size   Estimate       Adjustment   Degree of jaundice               Autism criteria                    Gestational age (wk)   Child age range (yr)   Study quality
  --------------------------------------------------- --------- -------------- ------------- -------------- ------------ -------------------------------- ---------------------------------- ---------------------- ---------------------- ---------------
  El-Baz, \[[@b9-kjp-2019-00815]\] 2011               Egypt     Case-control   300           Odds ratio     Crude        No reported                      DSM-4                              \<37                   2--13                  High
  Froehlich-Santino, \[[@b21-kjp-2019-00815]\] 2014   USA       Pros. cohort   388           Odds ratio     Crude        No reported                      ADI-R; ADOS                        No reported            4--18                  High
  Lozada, \[[@b11-kjp-2019-00815]\] 2015              USA       Case-control   11,668        Odds ratio     Adjusted     No reported                      ICD-9                              \<37                   3.8--7.2               High
  Zhang, \[[@b30-kjp-2019-00815]\] 2010               China     Case-control   19            Odds ratio     Crude        No reported                      ICD-10; CARS                       3--21                  38--40                 High
  Croen, \[[@b12-kjp-2019-00815]\] 2005               USA       Case-control   2,028         Odds ratio     Crude        TSB \> 15                        ICD                                \>35                   4--7                   High
  Chen, \[[@b19-kjp-2019-00815]\] 2014                Taiwan    Pros. cohort   10,080        Hazard ratio   Adjusted     No reported                      ICD-9                              40                     4--7                   High
  Finegan, \[[@b32-kjp-2019-00815]\] 1979             USA       Case-control   46            Odds ratio     Crude        TSB \> 16                        Clinical                           No reported            No reported            Low
  Piven, \[[@b31-kjp-2019-00815]\] 1993               USA       Case-control   78            Odds ratio     Adjusted     TSB \> 20                        ADI; ADOS                          36--41                 5--25                  High
  Maimburg, \[[@b26-kjp-2019-00815]\] 2008            Denmark   Case-control   946           Odds ratio     Adjusted     No reported                      ICD                                No reported            \<10                   High
  Jangaard, \[[@b22-kjp-2019-00815]\] 2008            Canada    Pros. cohort   55,671        Rate ratio     Adjusted     TSB \> 13.5                      Data linkage of the study cohort   \>35                   \<5                    High
  Sugie, \[[@b29-kjp-2019-00815]\] 2005               Japan     Case-control   1789          Odds ratio     Crude        Based on need for phototherapy   DSM                                38--40                 \<3                    High
  Buchmayer \[[@b36-kjp-2019-00815]\], 2009           Sweden    Case-control   6,776         Odds ratio     Adjusted                                      ICD                                No reported            \<10                   High
  Deykin, \[[@b20-kjp-2019-00815]\] 1980              USA       Cohort         364           Rate ratio     Adjusted     No reported                      Clinical                           No reported            6                      High
  Gillberg, \[[@b33-kjp-2019-00815]\] 1983            Sweden    Case-control   50            Odds ratio     Crude        TSB\>20                          Clinical                           36--41                 \>7                    Low
  Juul-Dam, \[[@b10-kjp-2019-00815]\] 2001            USA       Case-control   128           Odds ratio     Crude        TSB\>10                          ADI; ADOS                          \<37                   2.5--4                 High
  Matsuishi, \[[@b14-kjp-2019-00815]\] 1999           Japan     Case-control   232           Odds ratio     Crude        No reported                      DSM                                No reported            5--8                   High
  Mason-Brothers, \[[@b28-kjp-2019-00815]\] 1990      USA       Case-control   280           Odds ratio     Crude        No reported                      DSM                                No reported            0--5                   High
  Lord, \[[@b13-kjp-2019-00815]\] 1991                USA       Case-control   100           Odds ratio     Crude        No reported                      DSM                                No reported            6--10                  High
  Mamidala, \[[@b27-kjp-2019-00815]\] 2013            India     Case-control   942           Odds ratio     Adjusted     No reported                      ICD-10; CARS; DSM                  No reported            2--10                  High
  Maimburg, \[[@b23-kjp-2019-00815]\] 2010            Denmark   Cohort         733,826       Hazard ratio   Adjusted     No reported                      ICD-10                             33--42                 No reported            High
  Duan, \[[@b25-kjp-2019-00815]\] 2014                China     Case-control   572           Odds ratio     Adjusted     No reported                      CARS; DSM                          \>37                   3--6                   High

Adjusted to eliminate or reduce the effect of confounding variables on the association between neonatal jaundice and autism spectrum disorder among children.

DSM, Diagnostic and Statistical Manual of Mental Disorders; ADI-R, Autism Diagnostic Interview, Revised; ADOS, Autism Diagnostic Observation Schedule; ICD, International Classification of Diseases; CARS, Childhood Autism Rating Scales; ADOS, Autism Diagnostic Observation Schedule; Pros. Cohort, prospective cohort; Ret cohort, retrospective cohort.
